Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: South Korea Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20111
20121
20133
20141
20152
20162
20174
20182
20194
20203
20222
20232
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Terminated6
Active, not recruiting3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
AbbVie2
EMD Serono2
EMD Serono Research & Development Institute, Inc.2
Genentech, Inc.2
MedImmune LLC2
Novartis Pharmaceuticals2
Pfizer2
Ablynx, a Sanofi company1
Alumis Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic30
Lupus Erythematosus, Cutaneous3
Lupus Nephritis3
Lupus Erythematosus, Discoid2
Autoimmune Diseases1
Connective Tissue Diseases1
Immune System Diseases1

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.